Sponsor or institution

Clinical trials and research at Turning Point Therapeutics, Inc.

• 2Clinical trials
• 19Countries

All recruiting trials (2)

• Treatment with repotrectinib for young patients with specific genetic alterations in tumors

  This study is testing a new oral medication called repotrectinib to see if it can help young patients with advanced tumors that have certain genetic changes when other treatments haven't worked.

  Recruiting at 44 sites Phase 1/2 Turning Point Therapeutics, Inc. · Los Angeles, California and 67 other locations · NCT04094610

• Testing repotrectinib in patients with advanced solid tumors with specific gene rearrangements

  This study is testing a new drug called repotrectinib to see if it can help people with advanced solid tumors that have certain gene changes.

  Recruiting at 63 sites Phase 1/2 Turning Point Therapeutics, Inc. · Duarte, California and 164 other locations · NCT03093116

Quick answers

How many clinical trials run by Turning Point Therapeutics, Inc. are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 19 countries. The most sites are in Australia (2 trials), Canada (2 trials), Denmark (2 trials), France (2 trials), Italy (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →